Warsaw, United States
OrthoPediatrics, founded in 2006, is at the forefront of advancing the field of pediatric orthopedics, exclusively focusing on providing anatomically appropriate implants for children. With a headquarters in the United States, the company's vision is reflected in its commitment to delivering innovative technologies and quality products to assist surgeons globally.
The company leverages its industry-leading support and clinical education programs, expanding its offerings to cover essential areas such as Long Bone Deformity Correction, Trauma, Scoliosis, and Sports Medicine/Soft Tissue Repair. As a publicly traded entity since October 12, 2017, on Nasdaq under the symbol "KIDS", it has marked its dedication to growth and innovation.
In its latest financial maneuver, OrthoPediatrics secured an $80.00M Post-IPO Debt investment from MidCap Financial on January 8, 2024. This strategic investment will bolster its continued expansion and dedication to pediatric medical solutions, inviting further interest from potential investors.
